Dynamic systemic immune-inflammation index predicts survival after neoadjuvant immunotherapy in gastric cancer: A multicenter study

Summary: The systemic immune-inflammation index (SII), derived from platelet, neutrophil, and lymphocyte counts in peripheral blood, is linked to prognosis in several cancers. We evaluated whether changes in SII during neoadjuvant therapy could predict treatment outcomes in gastric cancer. A total o...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Hua-Long Zheng, Li-Li Shen, Chen-bin Lv, Jia Lin, Bin-bin Xu, Zhen Xue, Jun Lu, Zhi-Wei Zheng, Chang-Ming Huang, Jia-bin Wang, Chao-Hui Zheng
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Elsevier 2026-05-01
Saila:	iScience
Gaiak:	Oncology Therapeutics
Sarrera elektronikoa:	http://www.sciencedirect.com/science/article/pii/S2589004226009879
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!